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Abstract 
Vitellogenin (Vtg) induction in primary fish hepatocytes have been proposed as an in vitro 
screening assay for ER agonists and antagonists, but have not yet been used extensively as a 
high-throughput screening tool due to poor reproducibility, sensitivity and overall feasibility. 
The present work have evaluated the role of seasonal variation, normalization, optimal culture 
and assay conditions on the sensitivity, responsiveness and reproducibility of in vitro vtg gene 
and protein production in rainbow trout (Oncorhynchus mykiss) primary hepatocytes using the 
xenoestrogen 17α-ethynylestradiol (EE2) as a test chemical. The results show that primary 
hepatocytes display a relatively high individual and seasonal variation in both Vtg gene and 
protein induction potential, although less variance was observed in assay sensitivity. Data 
normalization of assay response to maximum (3 nM EE2) and minimum (DMSO) Vtg 
production dramatically reduced this variance and led to improved assay reproducibility. A 
time-dependent response was observed both for gene and protein expression, reaching 
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maximum Vtg induction after 96h of exposure, although reproducible concentration response 
curves for both Vtg mRNA and protein could be obtained already after 48h. A need for chemical 
re-exposure of the hepatocytes was identified to be important for sustaining exposure 
concentrations in extended studies (>48h), whereas different plate formats (96, 24 or 6 wells) 
did not affect the bioassay performance. In conclusion, standardization of hepatocyte bioassay 
and test conditions as well as data-normalization procedures are proposed to be instrumental 
for more consistent and comparable results in future use of this in vitro assay. 
Key words: Oncorhynchus mykiss, primary hepatocytes, EDCs, vitellogenin mRNA, protein  
 
1 Introduction 
The impact of endocrine disrupting chemicals (EDCs) on aquatic wildlife has been an issue of 
environmental concern for many years (Purdom et al., 1994). Endocrine disruptors, such as 
estrogen mimics,  are known to interfere with the endocrine system through activation of the 
estrogen receptor (ER) and cellular responses associated with normal sexual maturation and 
differentiation in fish (Hook et al., 2007). In recent years the potential challenge of 
environmental EDCs have been acknowledged and various international organizations (e.g. 
OECD, US-EPA, Japanese Environmental Agency) have proposed regulatory frameworks and 
test approaches to assess the potential hazard and risk of EDCs. The recent proposal of an 
OECD conceptual framework (CF) for testing and assessing EDCs has proposed to categorize 
different assays into 5 levels ranging from computational  efforts (CF1)  and in vitro screening 
(CF2) to in vivo testing (CF 3-5) based on their ability to address both mode of action (MoA) 
and adverse endpoints of regulatory concern (OECD, 2010). The OECD conceptual framework 
for ED testing and assessment proposes in vitro assays as a tool to prioritizing and characterize 
EDCs MoA, but suggest performing in vivo (CF level 4-5) studies for assessment of adversity 
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and in-depth characterization of the MoA  (OECD, 2010). However, it’s expected that the 
international effort to address EDCs will also increase the demand for toxicological testing 
(Hecker and Hollert, 2011). Implementation of the European Union chemical legislation 
REACH is estimated alone to generate a need for hazard assessment of over 30,000 single 
chemicals for various toxic properties, potentially requiring the use of millions of test animals 
(ECHA newsletter; Rovida and Hartung, 2009). Although the true number of chemicals that 
may require in vivo testing in REACH may still be unknown, the potential demand for an 
increase in regulatory testing clearly call for larger implementation of the 3R`s (Reduction, 
Refinement and Replacement) in animal testing and further development and evaluation of 
alternative (non-animal) methods for EDC testing. 
In vitro methods such as mammalian continuous cell lines and transgenic organisms 
(bacteria, yeast, and cells) have been proposed as suitable high-throughput screening (HTS) 
assays for EDCs at the OECD CF2 level (OECD, 2010). Development of in vitro methods for 
non-mammalian species such as fish has also been proposed, but only the fish embryo toxicity  
test have been validated for regulatory purposes (OECD, 2012b).  Nevertheless, induction of 
the estrogenic biomarker vitellogenin (Vtg) in fish hepatocytes is along with estrogen receptor 
/androgen receptor (ER/AR) binding affinity-, aromatase and steroidogenesis assays identified 
as potential candidates for inclusion as OECD CF level 2 assays (OECD, 2010). Primary 
cultures of fish hepatocytes retain many of the innate properties of the liver such as 
biotransformation activity, detoxification and ER mediated responses (Pedersen and Hill, 2000; 
Segner and Cravedi, 2000). Thus, vitellogenin induction in primary cultures of fish hepatocytes 
have successfully been implemented in screening of the ER agonistic and antagonistic 
properties of single chemicals, complex synthetic mixtures and environmental extracts (Kim 
and Takemura, 2003; Petersen and Tollefsen, 2011; Tollefsen et al., 2003; Tollefsen et al., 
2008b). The success of these in vitro bioassay have been ascribed a well-defined endocrine 
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MoA in oviparous fish, involving xenoestrogen binding to and activation of the ER (Mortensen 
and Arukwe, 2006; Petersen and Tollefsen, 2012; Tollefsen, 2002), transcription of Vtg mRNA 
(Mortensen and Arukwe, 2006; Scholz et al., 2004; Smeets et al., 1999) and subsequent 
translation into the functional protein (Tollefsen, 2002), that can be monitored and quantitated 
by a variety of different methods. Although clearly showing a screening potential, the feasibility 
of using these assays in EDC screening has been questioned due to low reproducibility, variable 
sensitivity and overall feasibility as high-throughput screening tools (Navas and Segner, 2006; 
Scholz et al., 2013). This applies in particular to the inter-species variability in Vtg gene and 
protein response often observed when exposed to the same xenoestrogen (Rankouhi et al., 
2004). The physiology of the donor fish has been proposed to be a major contributor to 
differences in estrogen sensitivity, where mature individuals induce Vtg at a higher magnitude 
of response than juveniles (Navas and Segner, 2006). The differences in reproducibility and 
sensitivity among cell batches and species may also be caused by differences in fish strains and 
cell isolation procedures within and amongst labs (Navas and Segner, 2006; Rankouhi et al., 
2004). Further, cell culture and bioassay conditions has been shown to also affect the assay 
performance and analytical determination of Vtg (Kim and Takemura, 2003; Pawlowski et al., 
2000; Tollefsen et al., 2003), thus illustrating the importance of assay protocol optimization and 
harmonization. As primary hepatocytes have been demonstrated to be a highly versatile multi-
endpoint experimental model (Farmen et al., 2010; Finne et al., 2007; Petersen and Tollefsen, 
2011; Tollefsen et al., 2008a; Tollefsen et al., 2006), thorough evaluation of assay performance 
and suggestions for improvements to facilitate larger implementation in EDC screening is 
therefore highly warranted. 
The aim of the present study was to evaluate the feasibility of primary rainbow trout 
(Oncorhynchus mykiss) hepatocytes as a potential screening assay for ER agonists. This was 
achieved by evaluating the role of seasonal variation in the Vtg (gene and protein) sensitivity 
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and responsiveness (e.g. induction potential), optimal culture and assay conditions (exposure 
time and well format), and the role of data normalization procedures using the model 
xenoestrogen 17α-ethynylestradiol (EE2). Chemical analysis of internal cell concentrations and 
media was additionally determined to assess the role of chemical depletion on bioassay 
performance. In addition, species-species and inter-laboratory differences in estrogen 
sensitivity were compared to identify key factors affecting the bioassay performance. 
2  Material and methods 
2.1 Chemicals 
All solvents and materials used in this study were obtained from the following sources: 17α-
ethynylestradiol (EE2, ≥98%, CAS 57-63-6) and d2 labelled estradiol (d2-E2, CAS 53866-33-
4) (>99%), sodium bicarbonate (CAS 144-55-8), sodium carbonate (CAS 497-19-8) , 
ammonium acetate (CAS 631-61-8), dansyl chloride (CAS 605-65-2) and copper sulfate 
(CuSO4·5H2O, CAS 7758-99- 8) were all purchased from Sigma–Aldrich (St. Louis, MI, US). 
Methanol (MeOH), acetone and toluene were of HPLC grade or analytical-reagent grade and 
obtained from Merck KGaA (Darmstadt, Germany). Dansylation buffer (pH 9.0) was prepared 
by dissolving 0.5g of sodium carbonate and 4.2g sodium bicarbonate in 200mL of HPLC grade 
water. All test chemicals (with the exception of copper sulfate which was prepared freshly in 
cell media) were dissolved in dimethylsulfoxide (DMSO) and stored at -20oC in the dark until 
use.   
2.2 Rainbow trout 
Juvenile rainbow trout (200-500g) from the same fish stock were obtained from the Valdres 
rakfisk BA hatchery (Valdres, Norway) and kept at the Department of Biosciences, University 
of Oslo for a minimum of 4 weeks prior to the start of the studies. The fish were kept at 6±2 oC, 
pH 6.6, 100% oxygen saturation under a 12h light/12h dark photo cycle. The fish were fed daily 
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with commercial pellets (Skretting, Stavanger, Norway) that corresponded to approximately 
0.5% of total body weight. 
2.3 Hepatocyte isolation 
Fish was collected from their rearing tanks in the period January-July (1-3 fish/sampling), 
terminated by a blow to the head and the abdominal cavity exposed by dissection. Only juvenile 
fish (with no visual gonads) were used in the 2-step hepatic cell isolation procedure described 
by Tollefsen et al. (2003). The in situ perfusion of the liver (5 ml/min, 10–15 min, 4oC) was 
performed using a calcium free perfusion buffer (4.8mM KCl, 1.2mM MgSO4, 122mM NaCl, 
11mM Na2HPO4,3.3mM NaH2HPO4, 3.7mM NaHCO3, 4 ◦C) with 26 µM EGTA to remove the 
blood from the liver and to disrupt cell-cell interactions. Digestion of connective tissues and 
dislodgement of cells was performed by perfusion (5 ml/min, 10–15 min, 35-40oC) with a 
calcium and EGTA free buffer containing collagenase (0.3 mg/ml) and CaCl2 (1.5 mM). The 
liver cells were thereafter transferred to a sterile glass beaker containing ice-cold calcium free 
perfusion buffer with 0.1% BSA, then homogenized by successive filtering through a 250µm 
and 100µm nylon mesh and centrifuged (500 rpm for 4, 3 and 3 min, 4oC) before being 
resuspended in a serum-free L-15 medium containing amphotericin (0.25 µg/ml), streptomycin 
(100 µg/l), penicillin (100 Units/ml), L-glutamine (0.29 mg/ml) and NaHCO3 (4.5 mM). A final 
filtration through a 100µm nylon mesh was performed prior to assessing the cell viability 
(>80%) using a Bürker counting chamber and trypan blue:cell suspension (2:1). The cell 
suspension was thereafter diluted to 500 000 cells/ml, seeded in 6- (6 ml), 24- (1.25 ml) or 96-
well (200 µl) PrimariaTM microtiter plates (Falcon, Becton Dickinson Labware, Oxnard, CA, 
USA ) and incubated in ambient atmosphere at 15oC. This temperature has previously been 
observed to yield the most sensitive concentration-response relationships for Vtg in rainbow 
trout hepatocytes (Tollefsen et al., 2008b). 
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2.3.1  In vitro exposure 
After 24 hours of acclimation of the cells in the wells, 50% of the media was removed and 
replaced with cell media spiked with the test chemical EE2 (0.001-300nM), positive control for 
cytotoxicity (0.078-10mM CuS04) and solvent control (0.1% DMSO) in triplicate. The cells 
were subsequently re-exposed after 48h of exposure to compensate for any depletion of the 
chemical from the medium. At the end of exposure, 100µl of cell media was sampled from each 
well and transferred to individual Maxisorp Nunc-immunoplates (Nunc, Roskilde, Denmark), 
sealed (Nunc, Roskilde, Denmark) and frozen for subsequent Vtg protein analysis by enzyme-
linked immunosorbent assay (ELISA). The cells were analyzed for cytotoxicity (96 well 
format) and total RNA was isolated (24 well plate format) for subsequent gene expression 
analysis. Sampling for Vtg protein and gene expression was performed after 24, 48, 72 and 96 
hours exposure and all samples were frozen at -80oC prior to analysis. 
2.4 Cytotoxicity 
Cytotoxicity was determined by measuring metabolic activity and cell membrane integrity, 
using Alamar Blue (AB) and 5-carboxyfluorescein diacetate acetoxymethyl ester (CFDA-AM) 
according to the method described by Tollefsen et al. (2008a). The cell media was removed 
from each well and replaced with 100µl of Tris buffer (50 mM, pH 7.5) containing 5% AB and 
4µM CFDA-AM, followed by incubation in the dark on an orbital shaker set to 100 rpm for 30 
minutes (room temperature). Fluorescence was measured at excitation- emission pairs of 530-
590nm (AB) and 485-530nm (CFDA-AM) by a Victor V3 multilabel counter (Perkin Elmer, 
Waltham, MA, USA). The viability data was expressed as relative cytotoxicity, where the data 
was normalized between solvent control (100% viability) and 0.1M CuSO4 (0% viability).   
2.5 Capture enzyme-linked immunosorbent assay (Capture ELISA) 
Vitellogenin was measured by a capture ELISA previously described by Tollefsen et al. (2003). 
In brief, frozen microtiter plates with samples were thawed at 4oC, 100µl of positive control 
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(plasma samples with 3-3000ng/ml Vtg) was applied to the control wells and the plates were 
incubated in the dark overnight (16h). The capture ELISA was carried out using mono-clonal 
mouse anti-salmon antibodies Vtg (BN-5, 1:6000x diluted in PBS with 1% BSA, Bioscense 
Laboratories, Bergen, Norway)  and the second antibody goat anti-mouse IgG (1:6000x diluted 
in PBS with 1% BSA, Bio-Rad, Herculeas, CA, USA) followed by addition of  HRP enzyme 
substrate (TMB plus, KEMENTEC diagnostics, Taastrup, Denmark) to start the color 
development. The plates were thereafter incubated in the dark at room temperature. The color 
development was stopped after 15-20 min with 50µl 1M H2SO4 and the plates were measured 
at 450nm using a Thermomax microplate reader (Molecular Devices, USA) within 20 minutes 
after H2SO4 addition. The relative Vtg expression was calculated as percentage of maximum 
vtg induction (3 nM EE2) at 96 hours of exposure or at individual exposure durations  of 24, 
48, 72 hours (3-30nM EE2) by normalizing against the solvent control, plotted and fitted to a 
sigmoidal concentration-response curve with a variable slope (Eq. 1).  
 
𝑙𝑜𝑔(𝑋) =  − 
𝑙𝑜𝑔
𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚
𝑌 − 𝐵𝑜𝑡𝑡𝑜𝑚  −  1
𝐻𝑖𝑙𝑙 𝑆𝑙𝑜𝑝𝑒
+ 𝑙𝑜𝑔𝐸𝐶50 
 
In Eq.1 the bottom value represents the minimum Vtg induction (solvent control) and the top 
value represents the maximum Vtg induction, fixed at 0 and 100 respectively. The hill slope 
represents the steepness of the curve, X value represents the fitted relative Vtg response and Y 
is the experimental Vtg response obtained from the Vtg ELISA analysis.         
Eq. 1 
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2.6 RNA isolation and quality assessment 
Total RNA was isolated using Qiagen RNeasy Plus mini kit (Qiagen GmbH, Hilden, Germany) 
according to the manufacturer instructions. Further concentration and purification of resulting 
RNA were performed with the ZYMO ZR-96 RNA Clean & Concentrator™ (Zymo Research, 
The Epigenetic company, USA). RNA concentration was measured spectrophotometrically 
(Spectrophotometer ND 1000, Nanodrop technologies Inc., Wilmington, USA) using the 
following quality cut-off criteria: 280/260 ratios of >2.0 and 260/230 ratios of >1.6. The RNA 
integrity of the samples was checked using Agilent BioAnalyzer RNA 6000 nano series kit 
(Agilent technologies, USA). All samples had RIN values >8, indicative of high RNA integrity 
(Fleige and Pfaffl, 2006). 
2.6.1 Quantitiative Real time PCR (qPCR) 
Quantitiative polymerase chain reaction (qPCR) was performed for the target gene Vtg and the 
reference gene ubiquitin (ubiq). Total RNA (0.5-1 μg) was reverse transcribed to cDNA using 
Quanta qScript™ cDNA Synthesis Kit (Quanta Biosences Inc., Gaithersburg, USA) according 
to the manufacturer’s instructions. Primer pair optimization was performed using a 5-step 
dilutions series (5-100 ng) in a 96 well plate format on a SFX-96 thermal cycler (Bio-Rad 
laboratories Inc., USA). The fluorescent dye SYBR®Green Supermix (Quanta Biosences Inc., 
Gaithersburg, USA) was used in the amplification reaction, where duplicates of 10 ng sample 
cDNA/well was pipetted in a final reaction volume of 20 μl/well. The vitellogenin primer pair 
was obtained from Celius et al. (2000) and the ubiquitin primer sequences were designed with 
Beacon designerTM and both were produced by Eurofins MWG synthesis GmbH (Ebersberg, 
Germany). The genes accession numbers and optimized primer assays are presented in table 1. 
All corresponding primers had a non-template control (NTC) to exclude any contamination of 
primer in the amplification reaction. A melting curve was determined for each primer to confirm 
specific amplification of each sample. Accepted threshold cycle (Cq) value of NTC was set to 
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be either non-detectable (N/A) or Cq value >30, ensuring a non-significant amount of quantified 
primer product. Ubiquitin was identified as a stable gene over all the treatments and used as a 
reference gene in normalization of gene signals by the ∆CT (2-∆∆Ct) method (Real-Time PCR 
application guide, Bio-Rad) (Table 1). 
2.7 EE2 chemical analysis 
Two mL of cell medium from a 24-well cell culture plate was transferred to a 10 mL glass 
reaction vial and 10 ng of internal standard (d2-E2) was added before the solution was extracted 
with 1.5 mL toluene by shaking for 5 min. The phases were allowed to separate and a 1 ml 
aliquot of the toluene layer was transferred to a 1.5 ml HPLC vial. Similarly, 10 ng of internal 
standard (d2-E2) was added to a 450 uL cell suspension which was extracted with 0.8 mL of 
toluene and a 0.5 ml aliquot of the toluene layer was transferred to a 1.5 ml HPLC vial. The 
toluene was evaporated to dryness under nitrogen. Derivatization of EE2 and d2-E2 was 
performed according to a previously published method by Fox et al. (2011). The dried sample 
extract was resuspended in 200 uL of 250 mM sodium carbonate/sodium bicarbonate buffer 
and 200 uL of 1 mg/mL dansyl chloride in acetone. After mixing, the solution was incubated 
for 30 min at 65 °C. Following, 50 uL of MeOH was added and the sample analyzed directly 
on UPLC-MS using a Waters BEH C8 (1.7 µm, 100 × 2.1 mm) with a Waters Acquity UPLC 
module (Waters Micromass, Manchester, UK). Analyte separation was achieved by linear 
gradient elution, starting from MeOH–water containing 2.6 mM ammonium acetate 20:80 v/v, 
rising to 98% MeOH over 9 min, held for 3 min, then switched back to the start-eluent. The 
UPLC system was coupled to a Waters Premier XE triple quadrupole mass spectrometer 
operating with an electrospray ionization (ESI) interface. Typical ESI parameters were a spray 
voltage of 2.5 kV, desolvation temperature at 400 °C, source temperature at 100 °C and cone 
gas and desolvation gas at 50 and 800 L N2/hour, respectively. The mass spectrometer was 
operated in MS/MS mode with argon as collision cell gas. Ionization and MS/MS collision 
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energy settings were optimized while continuously infusing (syringe pump) 100 ng/mL of the 
derivatized standards at 5 µL/min. Detection of the dansyl derivatized analytes was performed 
by multiple reaction monitoring (MRM) in positive ionization mode; EE2 dansyl 530.2>171.1 
and d2E2 dansyl 508.2>171.1. 
2.8 Data analysis and statistics 
Graphic design and statistical analysis were performed with Graphpad Prism Version 5.04 
software (GraphPad Software Inc., San Diego, CA, USA). The mean Vtg protein and mRNA 
expression with standard error of the mean (SEM) were fitted a concentration-response curve 
by non-linear regression. All data were log-transformed to fulfill criteria`s of normality and 
equal variances among groups. All data was tested with Bartlett`s test for equal variances 
followed by statistical analysis (p<0.05) using the t-test for pairwise comparison or analysis of 
variance (ANOVA) with Dunnett`s post-hoc test for dose-response curves.  
3 Results 
The reproducibility, sensitivity and responsiveness of Vtg gene and protein expression in the 
rainbow trout primary hepatocytes were assessed by evaluating the effect of seasonal variation, 
assay conditions (exposure time, and well format) and data normalization procedures. 
Verification of EE2 exposure concentration was performed to determine the role of cellular 
biotransformation and chemical loss of EE2 at different exposure concentrations. 
3.1 Cytotoxicity 
No cytotoxicity was observed in cells exposed to EE2 at any concentration or duration of 
exposure (24-96h) when compared to the solvent control (0.1% DMSO) and the cell media 
alone (data not shown). 
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3.2 Vitellogenin gene and protein expression 
The solvent control (DMSO) was found not to produce a significant increase in Vtg gene or 
protein response at any exposure time when compared to the response of the cell media alone 
(data not shown). 
3.2.1 Seasonal variation 
An inter-individual and seasonal (January-July) variation was observed in both Vtg protein and 
hepatic mRNA expression (Fig. 1). The inter-assay variability in Vtg mRNA and protein 
expression had no apparent coherence with season. The Vtg protein expression was described 
by concentration response curves (CRCs) with r2 > 0.7 at 96h of exposure (Fig 1). When 
compared (Fig. 2), the sensitivity of the protein response measured as the No Observed Effect 
Concentration (NOEC) varied 3-fold (0.03-0.1nM) and apparent maximum Vtg expression 
varied 2.4 fold (8.4-19.9 fold change from control). A larger inter-assay variation was observed 
in Vtg mRNA induction, where the NOEC varied 33 fold (0.003-0.1nM) while the 
responsiveness was highly variable (74-10 000 fold). A 6-23% reduction in Vtg mRNA and 
protein expression from the maximum levels was observed at concentrations above 30nM EE2 
(data not shown), but were considered being outside of the applicability range of the assay and 
therefore omitted from further analysis. 
3.2.2 Effect of exposure duration 
Evaluation of exposure duration was performed to assess whether it had an effect on Vtg gene 
and protein expression by exposing the cells for 24, 48, 72 and 96 hours to EE2 with re-exposure 
after 48 hours. A clear increase in Vtg protein expression was observed after 24h of exposure, 
although the data did not yield a high quality CRC due to low level of induction and high 
variation in the Vtg response (Fig. 3). Production of the Vtg protein increased with the duration 
of exposure, illustrated by a high quality CRC in the range 0.03-10 nM from 48 h exposure. 
Maximum Vtg protein expression was obtained after 96 hours of exposure to EE2 and an 
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apparent increase in assay responsiveness was observed with prolonged exposure time (Fig. 3 
and Table 2). A significant induction of the hepatic Vtg mRNA expression was observed already 
after 24 hours exposure to 1nM EE2 (Fig. 3), yielding a high quality CRC in the concentration 
range 0.03-10 nM EE2. The data show an apparent increase in assay sensitivity (24h EC10: 
0.0743nM, EC50: 0.923nM; 96h EC10: 0.0285nM, EC50: 0.381nM) with prolonged duration 
of exposure (Table 2), although these differences were not identified as being significantly 
different. Determination of the coefficient of variation (CV, %) for Vtg mRNA at 1nM EE2 
(Fig. 3), showed an irregular decrease that were not associated with the exposure duration (e.i. 
48% at 24h, 39% at 48h, 14% at 72h and 27% at 96h), which in protein expression was less 
variable with prolonged exposure (e.i. 77% at 24h, 41% at 48h, 17% at 72h and 8% at 96h). A 
deviation from ideal concentration-dependent response was observed as a reduction in Vtg 
expression for both protein and gene expression at concentrations in the range from 10-30 nM 
EE2 (results not shown). 
When normalized against the maximum Vtg response at 24, 48, 72 and 96 hours exposure to 
EE2, the data yielded high quality CRCs in both protein and mRNA expression in the 
concentration range 0.01-10 nM (Fig. 4 and Table 2). Vitellogenin protein and mRNA was 
expressed in a consistent manner between 48-96 hours (protein) and 24-96 hours (mRNA) (Fig. 
4) with similar EC-values at 24-72 hours, but displaying an apparent increase in Vtg 
responsiveness over time (Table 2). An apparent temporal increase in sensitivity, measured as 
a reduction in the EC10, was observed for both protein and mRNA expression (Table 2).  The 
cells exposed to EE2 for 24 hours did not produce a consistent Vtg protein expression and was 
thus omitted from the analysis. Vitellogenin protein expression varied considerably after 24 
hours of exposure despite normalization, but was greatly improved and comparable from 48-96 
hours of exposure. A large degree of consistency was found between the shape of the CRCs 
(Fig. 4) and ECs for protein and gene expression after 96h exposure (Table 2).  
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3.2.3 Effect of plate format 
The effect of well size exhibiting different volume/total surface ratios on induction of Vtg 
protein production was assessed by exposing the cells to EE2 for 48 and 96 hours in 96, 24, and 
6 well plates. No significant differences in sensitivity or responsiveness were observed in the 
Vtg protein induction (non-normalized data, results not shown) or the Vtg CRCs (normalized 
data, Fig. 5) for the different plate formats after 48- and 96 hours exposure.  
3.3 Chemical depletion of EE2 in the bioassay 
Verification of EE2 exposure concentration was performed in the 24-well format. When 
exposed to 3nM EE2 in a time dependent (0-48h) manner, cells were found to contain 70.7 
times higher concentration of EE2 than in the media within an hour of exposure (Fig. 6A). The 
EE2 concentration in the cells was fairly stable for 8 hours, before decreasing over time. 
Concentrations of EE2 in the media decreased already from the start of the exposures and 
throughout the 48 hour exposure period. When primary hepatocytes were exposed to 3 and 30 
nM EE2 for 0 and 48 hours (Fig. 6B),  measured EE2 concentrations in media were identified 
at 0 hours to be 74 and 93% of nominal EE2 concentration, albeit as little as 4 and 9% of 
nominal EE2 concentrations could be measured in media after 48hours exposure (Fig. 6B).    
4 Discussion 
Knowledge about the potential impact of endocrine disrupting chemicals (EDCs) on humans 
and the environment has increased substantially the last 20 years with the establishment of 
international EDC screening programs and regulatory guidelines (Hecker and Hollert, 2011). 
As the regulations for EDCs develop, a higher number of chemicals will require regulatory 
testing and tiered approaches using alternative (in silico and in vitro) methods to characterize 
EDCs are likely to surface as alternatives to resource-demanding and ethically challenging in 
vivo tests. Various international organizations are working towards a larger implementation of 
the 3R`s into integrated Approaches for Testing and Assessments (IATAs) and these initiatives 
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often involve using in silico methods such as (quantitative) structure activity relationship, 
structural alerts and category formation, and in vitro assays such as estrogen receptor (ER)- and 
androgen receptor (AR)-binding assay (OECD, 2012a; US-EPA, 2009; US-EPA, 2011). Well-
characterized in vitro methods such as the primary fish hepatocyte assay has shown to be a 
promising tool in the screening of estrogenic and anti-estrogenic chemicals, complex mixtures 
and environmental monitoring as they retain many of their native metabolic and biochemical 
properties (Petersen and Tollefsen, 2012, 2011; Segner and Cravedi, 2000; Tollefsen et al., 
2006; Tollefsen and Nilsen, 2008). However, large variations in sensitivity, responsiveness and 
reproducibility have been reported among laboratories and species (Navas and Segner, 2006) 
and thus proposed to limit the applicability of this assay within regulatory settings (Combes et 
al., 2006). Use of laboratory-specific strains of fish and lack of standardized guidelines, have 
made direct comparison between data and assays challenging. The present paper evaluated key 
properties to the primary hepatocyte assay’s performance, such as quantification of the Vtg 
response at the protein and mRNA level, role of seasonal variation, assay conditions (e.g. well 
plate format) and data normalization procedures to identify the assay`s applicability as a 
potential screening assay for ER-agonists. 
4.1 Seasonal variation 
It’s well documented that in vivo Vtg production varies throughout the season and maturation 
status of the fish (Bon et al., 1997; Larsson et al., 2002). This has led to the use of either male 
or juvenile fish in in vivo and in vitro studies for EDCs (Bickley et al., 2009; Tollefsen et al., 
2003). Use of juvenile or male fish as performed in the present and a number of studies 
elsewhere is thus expected to reduce a large source of variability, increase sensitivity towards 
estrogens, improve assay performance and allow inter-assay comparability (Bickley et al., 
2009; Navas and Segner, 2006). Despite such improvements, considerable variability in the 
maximal Vtg response (i.e the fold induction) at the protein and mRNA level was observed after 
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exposing primary hepatocytes from rainbow trout to EE2 in the present study. This level of 
variance in Vtg response has previously been reported in hepatocytes from bream (Abramis 
brama) and common carp (Cyprinus carpio) (Bickley et al., 2009; Rankouhi et al., 2004) and 
proposed being associated with a number of factors such as seasonal differences in the host fish 
physiology, rearing temperature and photoperiod, and in vitro culture conditions (Clark et al., 
2005; Pawlowski et al., 2000).  Changes in the basal activity of Vtg has previously been 
associated both with the seasonal changes in rearing temperatures by affecting the liver`s 
estrogen sensitivity and capacity to regulate ER and Vtg transcription, translation and post 
translation events downstream binding and activation of estrogen responsive elements (EREs) 
(MacKay et al., 1996; Mackay and Lazier, 1993). Elevated temperatures have also been 
demonstrated to affect the general cellular metabolism and specifically increase the expression 
of Vtg and ER mRNA both in vitro and in vivo (MacKay et al., 1996; Mackay and Lazier, 1993; 
Pawlowski et al., 2000). Other cellular processes such as biotransformation involving the aryl 
hydrocarbon receptor (AhR) and CYP1A may directly or indirectly be affected by changes in 
ER activity (Gräns et al., 2010; Mortensen and Arukwe, 2007) as well affect the transcriptional 
activation of the ER (Klinge et al., 1999) by potential unidirectional cross-talk (Bemanian et 
al., 2004). Besides temperature, maturation status of the donor fish has been proposed to affect 
the estrogen response in fish hepatocytes (Bickley et al., 2009; Smeets et al., 1999). Changes in 
Vtg expression and concentrations of nuclear and cytosolic ER with a factor up to 4 have been 
reported, although no correlation between the amount of natural estrogen E2 and induced 
nuclear and cytosolic ER could be determined (Smith and Thomas, 1991). Furthermore, the 
activity of the CYP-family is also reported to be closely associated with the reproductive cycle 
and seasonal maturation of fish (Koivusaari et al., 1984; Larsen et al., 1992), potentially 
affecting the biotransformation of the test compound. Despite suggestions of a number of 
factors that may affect regulation of circulating steroids and their biological activity (Clark et 
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al., 2005; Pawlowski et al., 2000), performance of the current study under a static photoperiod 
(in vivo rearing: 12h light/12h dark, in vitro culturing: in the dark), minor variations in 
temperature (in vivo rearing: 6±2 oC, in vitro culturing: 15±0.5 oC) and use of juvenile fish for 
all cell isolations have likely minimized any differences in responsiveness between different 
cell batches. It is therefore suggested that individual differences between cell batches are 
difficult to minimize further and any improvements in the assay performance will have to be 
performed through data normalization procedures (Bickley et al., 2009; Smeets et al., 1999). 
4.2 Data normalization 
Variation in production of Vtg has been proposed to be reduced by normalizing either to basal 
Vtg production calculating relative fold induction or to fit the responses within a minimum 
(basal) to maximal response relations to derive relative potencies (Bickley et al., 2009; Navas 
and Segner, 2006; Rankouhi et al., 2004). The Vtg production may also be reported as total 
quantity of protein or amount of RNA (ng)/well (Navas and Segner, 2006), but such 
normalization procedures will not minimize any data variations arising from different studies, 
although clearly improve the ability to perform absolute quantification. The strategy of the 
current exposure and analysis approach were developed to enhance sample throughput capacity 
(24 or 96 well format) and rapid detection by capture ELISA (protein detection) and/or qPCR 
(mRNA detection), and data normalization was best served by the relative potency approach. 
Implementation of this normalization procedure clearly improved the quality of the CRCs, 
minimized the inter-assay (e.g. cell batch) variation, and increased the reproducibility of both 
gene and the protein data considerably. Furthermore, the data normalization greatly improved 
the previously reported inter-cell batch variation, yielding high-quality CRCs for both Vtg 
mRNA and protein for different exposure durations. The variability in the 95% confidence 
interval of EC50 was greatly improved at 96 hours when data was normalized (non-normalized: 
50%, normalized: 31%), further increased the reproducibility and reliability of the primary 
18 
 
hepatocyte assay. The variation in Vtg protein expression between replicates ranged from 25% 
to 6 % when data were normalized at 96 hours, which was consistent with previous studies with 
primary salmon hepatocytes (Tollefsen et al., 2003). Although the current study used between 
four and seven donor fish, a minimum of four assays were normally found to sufficient to obtain 
high quality CRCs for both Vtg mRNA and protein expression.  
4.3 Bioassay-specific factors 
4.3.1 Effect of exposure duration 
Regulation of Vtg gene and protein production is a sensitive and time-dependent translation 
process from the molecular (gene) to the subcellular (protein) response. Hepatocytes exposed 
to EE2 for 24-96 hours expressed high-quality CRCs for Vtg mRNA already after 24 hours 
exposure when normalized using relative expression as performed for fish hepatocytes 
elsewhere (Bickley et al., 2009; Finne et al., 2007). In contrast, clear induction and high-quality 
CRCs for Vtg protein expression was first observed after 48 hours exposure. This is in 
compliance with exposure studies with Atlantic salmon hepatocytes exposed to E2 (Tollefsen 
et al., 2003), and likely reflect the time delay between mRNA transcription, translation and 
subsequent protein synthesis (Scholz et al., 2004) and transport of the protein to the exterior of 
the hepatocyte. Although gene expression was initiated earlier than 24 hours, consistent 
induction of both Vtg mRNA and protein production may require as much as 48 hours of 
exposure to produce high-quality CRCs (Bickley et al., 2009; Gagné and Blaise, 1998; Scholz 
et al., 2004; Tollefsen et al., 2003). Prolonging the exposure duration to 72 and 96 hours 
improved the magnitude of both the mRNA and protein Vtg response (Table 2). Optimal 
exposure time was identified as 96 hours whereupon both the Vtg protein and mRNA expression 
showed an apparent increase in the assay sensitivity, responsiveness and reduced CV, consistent 
with previous studies performed on primary salmon hepatocytes exposed to E2 (Tollefsen et 
al., 2003). However extending the duration from 48 to 96 hours of exposure, required chemical 
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re-exposure as the concentration of EE2 in the wells was reduced to less than 50% after 24 
hours of exposure and almost depleted within 48 hours (Fig. 6A). Such rapid depletion has 
previously been observed for E2 and accredited high biotransformation activity in rainbow trout 
hepatocytes and liver preparations (Miller et al., 1999; Schmieder et al., 2004). These 
observations are in agreement with observations that E2 require re-exposure after 48 hours to 
maintain reproducible CRCs (results not shown). The observed relationship between nominal 
and measured concentration of EE2 obtained herein suggests a concentration-independent 
depletion of EE2 (Fig. 6B), thus confirming that the hepatocyte are highly metabolically 
capable (Pedersen and Hill, 2000; Segner and Cravedi, 2000). Despite the clear advantages of 
having metabolically active cells to mimic the natural biotransformation and thus potentially 
detect both estrogenic mother compounds and their metabolites (Nillos et al., 2010; Pedersen 
and Hill, 2000; Segner and Cravedi, 2000), the rapid depletion occurring may challenge 
accurate calculation of effective concentration or potencies for metabolically susceptible EDCs 
(Lindholst et al., 2003). Although routine measurement of exposure concentrations in in vitro 
bioassays are clearly a complicating factor that will limit sample throughput, lack of consistency 
between in vitro potency and in vivo toxicity (Tollefsen et al., 2008a) may require analytical or 
computational corrections to adjust for chemical depletion in bioassays such as primary 
hepatocytes. 
4.3.2 Plate format 
The different plate formats used in chemical exposures often reflects the samples need for the 
down-stream endpoint analysis. Determination of viability and high-throughput use of various 
biochemical probes are often conducted in the 96 well plate formats (Farmen et al., 2010; 
Tollefsen et al., 2008b), whereas sublethal effects such as gene expression may require either 
24 or 6 well formats to ensure sufficient biological material for analysis using most cDNA 
construction protocols (Finne et al., 2007). Use of different plate formats with different volume 
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to surface ratios may thus introduce confounding bioassay factors such as differences in 
sorption to and possible interaction with the plastic surface (Schreiber et al., 2008). Such 
confounding factors may potentially affect the freely dissolved concentration of hydrophobic 
chemicals (log Kow >3) in the bioassay and result in overestimation of the chemicals actual 
concentration in the assay (Brown et al., 2001; Mayer et al., 1999; Riedl and Altenburger, 2007). 
Despite potential for such confounding factors, no significant difference in Vtg protein 
production was observed in assays run in 6, 24 or 96 well formats with different total surface-
volume ratio after 48 and 96 hours of exposure. Although this holds true for EE2, larger 
discrepancies may be expected for chemicals that are more hydrophobic and volatile than EE2. 
4.4 Bioassay performance 
Exposure to EE2 for 24-96h caused a sensitive, responsive and reproducible induction of Vtg 
gene and protein production similar to that observed for primary salmonid hepatocytes (Olsen 
et al., 2005; Tollefsen et al., 2003).  However, deviation from ideal CRCs for both Vtg protein 
and mRNA expression at higher concentrations of EE2 (10-30nM) in the primary rainbow trout 
hepatocytes suggest that EE2 cause complex cellular responses that are not accounted for by 
pure receptor-mediated responses alone. This has been reported in rainbow trout, bream and 
carp hepatocytes previously, although the rationale for such discrepancy is currently not 
understood (Petersen and Tollefsen, 2011; Rankouhi et al., 2004).  Unpublished global 
transcriptional analysis using materials generated in the same bioassay as used herein show a 
14% lower expression of ERα at 30nM compared to the second highest concentration (3nM), 
thus suggesting that part of the reduction in Vtg observed is mediated through regulation of the 
activity of the ER (results not shown).  Phase II biotransformation enzymes, involved in the 
steroid homeostasis (UDP-glucuronosyl transferase) and phase III biotransformation (ABC-
family transporters), involved in steroid transport were also induced at this concentration, thus 
may potentially lead to a reduction in the cellular level of EE2 and consequently also ER and 
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Vtg mRNA expression. Other factors such as concentration-dependent ER desensitization, 
receptor competition, receptor down regulation and /or negative endocrine feedback loops, 
receptor cross-talk and induction of sex steroid-binding proteins (SBPs) that limit cellular 
access of EE2 (Foucher et al., 1991; Gräns et al., 2010; Nagel et al., 1998; Nagel et al., 1997; 
Vandenberg et al., 2012) are additional explanations to the relative reduction in the Vtg response 
at high EE2 concentrations.  
4.5 Inter-laboratory and inter-species differences  
Large variances in estrogen sensitivity (LOEC: 10-12 to 10-7 M) and Vtg responsiveness have 
previously been reported in primary hepatocytes among different laboratories and donor species 
(Supplementary table A) (Navas and Segner, 2006). In an attempt to address this issue, a 
comparison of relevant in vitro bioassays (primary hepatocytes, liver slices, liver homogenate) 
was performed as to identify potentially contributing factors to the observed intra- and inter 
species bioassay`s estrogen sensitivity (Suppl. Table A). The ER-sensitivity has previously been 
suggested as one of the contributing factors to the inter-species discrepancies of in vitro Vtg 
responses (Rankouhi et al., 2004). However when comparing ER relative binding affinity (ER-
RBA) for EE2 in four different cold and warm water species it differed no more than 10 fold 
(Table 3), which is in compliance with previous inter-species comparisons of RBA for fish ERs 
(Denny et al., 2005). Somewhat higher differences (<200-fold) were observed when comparing 
the Lowest Observed Effect Concentration (LOEC) for in vivo Vtg-induction in the same 
species (Table 4, Suppl. Table B). Interestingly, the LOECs for rainbow trout in vitro and in 
vivo Vtg-induction differed with no more than 2-19 fold for E2, which was within the range of 
variation (0-19.5 fold change) of the LOECs for in vivo Vtg-induction in cold water species 
alone  (Table 3 and 4). However, orders of magnitude differences (2-367 000 fold) were 
observed when comparing the in vitro Vtg- sensitivity in primary hepatocytes from cold- and 
warm-water species (Table 3), thus suggesting that factors related to the in vitro bioassays were 
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the main reason for the large discrepancy. Bioassay factors such as cell incubation temperature, 
cell density, culture plate formats and especially media supplements (e.g. fetal bovine serum, 
Ultroser SF) varied greatly within and among the bioassays based on warm-water species. Such 
in vitro culturing factors have previously been demonstrated to significantly affect Vtg 
induction, as well as metabolism and bioavailability of the exposure chemicals (Pawlowski et 
al., 2000; Tollefsen et al., 2003). Additionally, the selection of Vtg gene transcripts (eg.Vtg 1,Vtg 
3) used in the gene expression analysis may contribute to the observed discrepancies as they 
may have different estrogen responsiveness (Martyniuk et al., 2007). The present comparison 
suggests that inter-laboratory factors and bioassay conditions (eg. incubation temperature, 
media supplements, cell density etc.) are the largest contributors to the observed Vtg variability 
of sensitivity and responsiveness among and within species. In additional to these confounding 
bioassay factors, different analytical approaches for determining Vtg and normalization 
procedures are applied across laboratories, making the results difficult to compare (Navas and 
Segner, 2006). It is evident that there is still a need for intra-species protocol standardization of 
rearing temperatures, cell isolation procedures, bioassay conditions, analytical approaches and 
data normalization procedures to reduce inter-assay and inter-laboratory variability. 
4.6 Future directions for use of fish hepatocytes 
The present work has demonstrated that rainbow trout primary hepatocyte`s are sensitive, 
reproducible and responsive when exposed to the estrogen agonist EE2. The primary 
hepatocytes variable capacity to induce Vtg gene and protein could not fully be associated with 
either seasonal or variable inter-cell batch endocrine regulation. Although differences in 
incubation temperature and inter-cell batch variation might have affected the Vtg response, this 
variation was dramatically reduced by data normalization. The present paper also briefly 
addressed the inter-lab and inter-species variability in Vtg sensitivity and concluded that there 
is a need for larger standardization of the primary hepatocyte culture and exposure protocols. 
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Future assay standardization should consider use of serum-free exposure media, fixed intra-
species incubation temperatures, standardized bioassay cell density and verification of chemical 
exposure concentrations to account for depletion of chemicals in the bioassays. Chemical 
bioavailability of hydrophobic chemicals has proven particularly challenging due to various 
bioassay factors (e.g. chemical depletion, well format, wall sorption) in which partition-driven 
administration dosing may alleviate some of the problems (Booij et al., 2011; Kwon et al., 2009; 
Riedl and Altenburg, 2007; Schreiber et al., 2008; Smith et al., 2009). Development of 
continuous liver cell lines or use of cryopreserved primary hepatocytes, which retain properties 
of freshly isolated hepatocytes (Markell et al., 2014; Mingoia et al., 2010), may additionally 
reduce inter-lab and inter-assay variance to a level that accommodate suitable high-throughput 
screening formats (Bols et al., 2005; Petersen and Tollefsen, 2012, 2011; Tollefsen et al., 2008b; 
Tollefsen et al., 2003). 
5 Conclusion 
The present study has shown primary rainbow trout hepatocytes to be a sensitive, reproducible 
and responsive in vitro model. The confounding effect of inter-individual-, inter-assay- and 
seasonal variations in Vtg protein expression and mRNA induction were reduced when data 
normalization procedures were implemented. Standardization of protocols for cell culture 
conditions, exposure procedures, chemical verification and data normalization has the potential 
to reduce inter-assay and inter-laboratory variance in use of primary hepatocytes for screening 
of ER-agonists. Implementation of more harmonized efforts in bioassay testing with primary 
hepatocytes should thus be expected to increase the assay`s potential as an experimental model. 
The present proposal for optimization and standardization of protocols will hopefully facilitate 
improvement of the assay`s robustness, reproducibility, sensitivity and render this assay more 
applicable to lower tier regulatory testing strategies (e.g an OECD CF2 assay). 
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